Legados, Jhuliuz Kaeden O.

HRN: 20-94-76  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2026
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
06/30/2026
07/07/2026
PO
3ML
BID
TBI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Central Nervous System    Compliance to guidelines: